2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Advances In Cancer Research And Treatment
Advances in cancer research and treatment have been transformative, offering new hope for patients worldwide. Breakthroughs in immunotherapy have enabled treatments that harness the body's immune system to target and destroy cancer cells more effectively. Targeted therapies, which focus on specific molecules involved in cancer growth, have made it possible to personalize treatment plans, minimizing side effects and improving outcomes. Additionally, advancements in precision medicine are allowing for more accurate diagnosis and tailored therapies based on an individual’s genetic makeup. Clinical trials continue to explore innovative approaches, such as gene editing and cancer vaccines, which promise even greater potential for remission and prevention. These evolving treatments bring us closer to a future where cancer may become a manageable or even curable condition, significantly improving the quality of life for patients.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China